[artículo] 
inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 3 (Junio) . - pp. 281-286

Título :	Association between citalopram serum levels and clinical improvement of patients with major depression
Tipo de documento:	texto impreso
Autores:	Haji Ostad, Autor ; Allahyari Elnaz, Autor ; André Tadic, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 281-286
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastorno depresivo mayor, Antidepresivo, Citalopram, Concentración sérica, Monitorización de fármacos terapéuticos
Resumen:	Imaging studies have shown that serum concentrations of the selective serotonin reuptake inhibitor citalopram correlate with serotonin transporter (5-HTT) occupancy in vivo. In patients with major depressive disorders treated with citalopram, 80% 5-HTT occupancy was considered to be necessary for maximal therapeutic effects, which requires citalopram serum concentrations of at least 50 ng/mL.
Link:	./index.php?lvl=notice_display&id=29374

[artículo] Association between citalopram serum levels and clinical improvement of patients with major depression [texto impreso] / Haji Ostad, Autor ; Allahyari Elnaz, Autor ; André Tadic, Autor . - 2022 . - pp. 281-286.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 3 (Junio) . - pp. 281-286

Palabras clave:	Trastorno depresivo mayor, Antidepresivo, Citalopram, Concentración sérica, Monitorización de fármacos terapéuticos
Resumen:	Imaging studies have shown that serum concentrations of the selective serotonin reuptake inhibitor citalopram correlate with serotonin transporter (5-HTT) occupancy in vivo. In patients with major depressive disorders treated with citalopram, 80% 5-HTT occupancy was considered to be necessary for maximal therapeutic effects, which requires citalopram serum concentrations of at least 50 ng/mL.
Link:	./index.php?lvl=notice_display&id=29374